AR065588A1 - Un medicamento para tratar enfermedad pulmonar obstructiva cronica - Google Patents

Un medicamento para tratar enfermedad pulmonar obstructiva cronica

Info

Publication number
AR065588A1
AR065588A1 ARP080100890A ARP080100890A AR065588A1 AR 065588 A1 AR065588 A1 AR 065588A1 AR P080100890 A ARP080100890 A AR P080100890A AR P080100890 A ARP080100890 A AR P080100890A AR 065588 A1 AR065588 A1 AR 065588A1
Authority
AR
Argentina
Prior art keywords
pulmonary disease
chronic obstructive
obstructive pulmonary
medicinal product
treat chronic
Prior art date
Application number
ARP080100890A
Other languages
English (en)
Inventor
Yoichi Yabuuchi
Kounori Kotosai
Original Assignee
Otsuka Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharma Co Ltd filed Critical Otsuka Pharma Co Ltd
Publication of AR065588A1 publication Critical patent/AR065588A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
    • A61K31/10—Sulfides; Sulfoxides; Sulfones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/075—Ethers or acetals
    • A61K31/085—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon
    • A61K31/09—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon having two or more such linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4704—2-Quinolinones, e.g. carbostyril
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pulmonology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Medicamento para tratar enfermedad pulmonar obstructiva cronica que comprende como ingredientes activos un derivado de carboestirilo de la formula (1), en donde A es un grupo alquileno inferior, R es un grupo cicloalquilo, el enlace entre lasposiciones 3 y 4 del esqueleto de carboestirilo es un enlace simple o un enlace doble, o una de sus sales; y probucol.
ARP080100890A 2007-03-09 2008-03-03 Un medicamento para tratar enfermedad pulmonar obstructiva cronica AR065588A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2007059664 2007-03-09

Publications (1)

Publication Number Publication Date
AR065588A1 true AR065588A1 (es) 2009-06-17

Family

ID=39431212

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP080100890A AR065588A1 (es) 2007-03-09 2008-03-03 Un medicamento para tratar enfermedad pulmonar obstructiva cronica

Country Status (20)

Country Link
US (1) US20100048621A1 (es)
EP (1) EP2120904A1 (es)
JP (1) JP5265580B2 (es)
KR (1) KR101442874B1 (es)
CN (1) CN101631538B (es)
AR (1) AR065588A1 (es)
AU (1) AU2008225372B2 (es)
BR (1) BRPI0808344A2 (es)
CA (1) CA2678920C (es)
HK (1) HK1140136A1 (es)
IL (1) IL200436A0 (es)
MX (1) MX2009009634A (es)
MY (1) MY151196A (es)
NZ (1) NZ579186A (es)
RU (1) RU2451507C2 (es)
SG (1) SG179440A1 (es)
TW (1) TWI352593B (es)
UA (1) UA95830C2 (es)
WO (1) WO2008111662A1 (es)
ZA (1) ZA200905854B (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108299263B (zh) 2018-01-30 2020-12-01 北京德默高科医药技术有限公司 一种普罗布考衍生物及其制备方法与应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5535019A (en) 1978-09-01 1980-03-11 Otsuka Pharmaceut Co Ltd Carbostyryl derivative
JPS5649378A (en) 1979-08-25 1981-05-02 Otsuka Pharmaceut Co Ltd Tetrazolylalkoxycarbostyril derivative
JP2574099B2 (ja) 1992-05-21 1997-01-22 大塚製薬株式会社 アレルギー疾患治療剤
JPH10175864A (ja) * 1996-12-16 1998-06-30 Otsuka Pharmaceut Co Ltd 慢性閉塞性肺疾患治療剤
US6852878B2 (en) * 1998-05-14 2005-02-08 Atherogenics, Inc. Thioketals and thioethers for inhibiting the expression of VCAM-1
AU1387399A (en) * 1997-11-10 1999-05-31 Vyrex Corporation Probucol esters and uses thereof
US7323496B2 (en) * 1999-11-08 2008-01-29 Theracos, Inc. Compounds for treatment of inflammation, diabetes and related disorders
ITMI20020597A1 (it) * 2002-03-22 2003-09-22 Nicox Sa Derivati del probucolo
AU2003253887A1 (en) * 2002-07-12 2004-02-02 Atherogenics, Inc. Novel salt forms of poorly soluble probucol esters and ethers
WO2005112914A2 (en) * 2004-04-20 2005-12-01 Atherogenics, Inc. Phenolic antioxidants for the treatment of disorders including arthritis, asthma and coronary artery disease
BRPI0616223A2 (pt) * 2005-09-15 2011-06-14 Otsuka Pharma Co Ltd combinaÇço de fÁrmacos

Also Published As

Publication number Publication date
US20100048621A1 (en) 2010-02-25
UA95830C2 (ru) 2011-09-12
HK1140136A1 (en) 2010-10-08
CA2678920C (en) 2013-10-29
IL200436A0 (en) 2010-04-29
EP2120904A1 (en) 2009-11-25
TWI352593B (en) 2011-11-21
SG179440A1 (en) 2012-04-27
BRPI0808344A2 (pt) 2014-07-29
RU2451507C2 (ru) 2012-05-27
AU2008225372B2 (en) 2012-12-20
AU2008225372A1 (en) 2008-09-18
CN101631538A (zh) 2010-01-20
KR20090119988A (ko) 2009-11-23
TW200836734A (en) 2008-09-16
JP2010520872A (ja) 2010-06-17
MX2009009634A (es) 2009-09-22
JP5265580B2 (ja) 2013-08-14
WO2008111662A1 (en) 2008-09-18
ZA200905854B (en) 2010-05-26
RU2009137378A (ru) 2011-04-20
NZ579186A (en) 2011-05-27
MY151196A (en) 2014-04-30
KR101442874B1 (ko) 2014-09-19
CA2678920A1 (en) 2008-09-18
CN101631538B (zh) 2011-11-16

Similar Documents

Publication Publication Date Title
AR066664A1 (es) Un medicamento para tratar enfermedad de alzheimer
CO6480932A2 (es) Antagonistas de la trayectoria hedgehog de ftalazina disustituida.
GT201200164A (es) "nuevos compuestos de espiropiperidina"
CO6491060A2 (es) Compuestos y composiciones para el tratamiento de enfermedades parasitarias
AR059948A1 (es) Formas farmaceuticas y metodos de tratamiento que usan un inhibidor de la tirosinacinasa
SV2010003491A (es) 2- anilinopurin-8-onas como inhibidores de ttk/mps1 para el tratamiento de trastornos proliferativos
HN2008001374A (es) Compuestos de cinamida policiclicos
UY30267A1 (es) Nuevos derivados de la tioxantina , composiciones farmacéuticas que los contienen, procedimientos de preparacion y aplicaciones
PE20121520A1 (es) Formulacion farmaceutica que comprende ranolazina y dronedarona en el tratamiento de fibrilacion auricular
DOP2006000170A (es) Nuevos derivados de espirocromanona
CU20140072A7 (es) Derivados de dihidro-oxazina y dihidro-pirido-oxazina
EA201001733A1 (ru) Производные тиенопиридона в качестве активаторов амр-активированной протеинкиназы (амрк)
ECSP088414A (es) Derivados de ácido bifeniloxiacético para el tratamiento de una enfermedad respiratoria
CY1115058T1 (el) Παραγωγα 1,2,3- τριαζολης για χρηση ως αναστολεις στεατοϋλο-coa δεσατουρασης
UY30835A1 (es) 8-alquinilxantinas y derivados
UY31310A1 (es) Ácidos 6-fenilnicotínicos sustituidos y su uso
AR077139A1 (es) Composiciones farmaceuticas utiles para tratar el vch
ECSP11010992A (es) Derivados de anilina-pirimidina sustituidos con sulfoximina como inhibidores de quinasas dependientes de ciclina (cdk), producción y uso de los mismos como productos medicinales
DOP2012000058A (es) Agente terapeutico para trastornos del estado de animo
CO6480931A2 (es) Sulfonamidas heterocíclicas, usos y composiciones farmacéuticas de las mismas.
AR067446A1 (es) Un medicamento para tratar higado graso que comprende cilostazol
UY30585A1 (es) Derivados de isoserina como inhibidores del factor ixa de la coagulacion
CO2022015630A2 (es) Pirrolopirimidinaminas como inhibidores del sistema del complemento
CO6361995A2 (es) Derivados de isoquinolinona como antagonistas de nk3
BR112017023076A2 (pt) derivados do ácido ciclopropanocarboxílico e seus usos farmacêuticos

Legal Events

Date Code Title Description
FB Suspension of granting procedure